Ching‐Tien Peng

Prophylaxis vs. on‐demand treatment with BAY 81‐8973, a full‐length plasma protein‐free recombinant factor VIII product: results from a randomized trial (LEOPOLD II)

Renchi Yang, L. Rusen, H. Beckmann et al. · Journal of Thrombosis and Haemostasis · 2014 · 88 citations · Full text

Medicine, Hematology, Pharmacotherapy +13

Safety monitoring of cardiac and hepatic systems in β‐thalassemia patients with chelating treatment in Taiwan*

Ching‐Tien Peng, Kuan‐Chih Chow, Jeon‐Hor Chen et al. · European Journal Of Haematology · 2003 · 55 citations

Medicine, Hematology, Pharmacology +17

Interleukin 4, interleukin 6 and interleukin 10 polymorphisms in children with acute and chronic immune thrombocytopenic purpura

Kang‐Hsi Wu, Ching‐Tien Peng, Tsai‐Chung Li et al. · British Journal of Haematology · 2005 · 51 citations · Full text

Life Sciences, Immunology, Pediatrics +17

Association Analysis of γ2 Subunit of γ-Aminobutyric Acid Type A Receptor Polymorphisms with Febrile Seizures

I‐Ching Chou, Ching‐Tien Peng, Chao Huang et al. · Pediatric Research · 2003 · 51 citations

Life Sciences, Genetics, Neuroscience +14

Human RhDel is caused by a deletion of 1,013 bp between introns 8 and 9 including exon 9 of RHD gene.

Jan‐Gowth Chang, Jyh‐Chwan Wang, Tzu-Yao Yang et al. · PubMed · 1998 · 51 citations

Life Sciences, Genetics, Molecular Genetics +7